Altria is pessimistic about the future of Juul and its investment in the company but does not think the time has come to pull the plug just yet.
The US tobacco company does see the near future as absolutely pivotal to the make-up of tobacco alternatives in the country and has said it is up to the US Food and Drug Administration (FDA) to make the right calls on authorisations to allow products on the market.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.